Dosage-form words can hide a more basic question: which medicine is this? Rugiet Daily Boost identifies daily tadalafil plus DHEA in a cinnamon chew. Although this publication focuses on formulations, the review also follows the product's cost and evidence because a liquid, chew or tablet description alone cannot establish equivalence, benefit or suitability.
The exact product
The distinguishing formulation issue is a hormone-precursor ingredient alongside tadalafil. Keep three fields separate: active ingredients, physical preparation and prescribed administration. Chewable, sublingual and swallowed are not interchangeable instructions. If a product page and safety document use different words, ask the dispensing pharmacist to identify the actual preparation. This review does not infer mixing, holding, chewing or swallowing directions from packaging or from another seller's product.
| Detail | Record |
|---|---|
| Provider | Rugiet |
| Listed active ingredients | Tadalafil + DHEA |
| Dosage form | Compounded daily cinnamon chew |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Rugiet: Daily Boost product information |
Price, supply and payment
The public price record is Complete product plan price not verified. Compare that figure only after establishing the exact formulation and supplied quantity. A unit can mean a tablet, chew, gummy, shot or allocated dose, and those words do not establish identical clinical exposure. Where quantity or billing period is missing, a cost-per-treatment calculation remains unsupported. Ask for the pharmacy label and complete invoice fields rather than treating package appearance as a measure of supply.
| Detail | Record |
|---|---|
| Earlier trial | 40 selected men; six months; not a Boost study |
| Later trial | 86 randomized; 79 completed; no significant sexual-function differences |
| Price boundary | Full product-specific plan not verified |
| Different from Hims support product | DHEA is not the zinc/arginine/vitamin formula |
What the research can support
Formulation changes can limit how evidence transfers. The source context here is a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit, leaving applicability of those studies to the exact Boost preparation unanswered. A shared active ingredient does not prove matched absorption, timing, stability or outcomes across preparations. Research on an intranasal, swallowed or separately dosed medicine cannot automatically validate a fixed sublingual or compounded product. The finished prescription needs evidence appropriate to the claim being made.
| Detail | Record |
|---|---|
| Evidence boundary | a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit |
| Not established here | applicability of those studies to the exact Boost preparation |
| Clinical and regulatory references | Reiter et al. (1999): DHEA and erectile dysfunction · Morales et al. (2009): androgens and sexual function · MedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil |
Safety questions for the prescriber
A different physical format does not remove medication interactions. The clinician needs to know about nitrates, nitrites, riociguat, other ED products and blood-pressure treatment, along with relevant health conditions. Do not recreate Rugiet Daily Boost by combining or manipulating separate medicines. A pharmacist should clarify the supplied label, storage and handling; personal suitability and any treatment change need the prescribing team's involvement.
| Detail | Record |
|---|---|
| DHEA | A hormone precursor; different studies do not establish the exact combination’s benefits or suitability. |
Availability and the actual prescription
The formulation record has this access limit: Public product listing; individual eligibility and current prescription require confirmation. A safety entry demonstrates documentation, not necessarily a currently supplied product. When an offer changes, the preparation, pharmacy or instructions may also change. Confirm all three instead of assuming a familiar brand name preserves the old directions. Public text cannot verify the exact medicine that would be dispensed to an individual account.
Refills, changes and cancellation
Keep the supplied label available when asking about response or tolerability. Report the exact product and how its prescribed instructions were followed; do not improvise a different route to seek faster effects. A focused question is “What finding supports DHEA in my case, and how will its effects be assessed?” If the clinician changes the formulation, ask which instructions and storage requirements now apply and confirm that the next shipment contains the intended preparation.
| Detail | Record |
|---|---|
| Membership | 30- and 90-day membership terms; confirm fees and the complete product invoice. |
| Cancellation terms | Terms specify 72 hours before billing; support mentions 24 hours before processing. |
| Timing distinction | Different deadlines refer to different events; confirm the rule for the selected order. |
| Refund boundary | Processing prevents cancellation; ordinary lack of efficacy, side effects or flavor are not refund grounds. |
| Policy sources | Rugiet: terms and conditions · Rugiet Support: canceling an order or subscription · Rugiet Support: treatment response and refunds · Rugiet Support: membership options and inclusions |
Compare named products
The comparison links are chosen to expose meaningful formulation differences. Read the complete active list before deciding that two chews, two tablets or two liquids are alike. Conversely, a different package does not prove a different clinical benefit. Consider ingredient, preparation, schedule and evidence separately so that a preference about administration can be discussed without becoming an unsupported equivalence claim.
Questions to keep with the offer
No sample of Rugiet Daily Boost was examined for this review. We did not measure concentration, dissolution, stability or patient outcomes, and public descriptions do not substitute for those tests. The source record is useful for identifying questions about a finished prescription, not for compounding instructions or dose conversion. The pharmacy and prescriber must resolve the actual label and use directions.
| Detail | Record |
|---|---|
| Ask about this formula | What finding supports DHEA in my case, and how will its effects be assessed? |
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Source records
These records have different purposes. A provider page documents its public wording; it does not independently verify a supplied product, a patient result or the service behind the claim.
- Rugiet: Daily Boost product informationProvider product page; tadalafil and DHEA combination · Checked 2026-10-07
- Reiter et al. (1999): DHEA and erectile dysfunctionPrimary placebo-controlled study, 40 selected men; indexed abstract reviewed · Checked 2026-10-07
- Morales et al. (2009): androgens and sexual functionPrimary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit · Checked 2026-10-07
- Rugiet: terms and conditionsProvider policy; 72-hour subscription cancellation notice and refund eligibility · Checked 2026-10-07
- Rugiet Support: canceling an order or subscriptionProvider support; member portal steps and processing restrictions · Checked 2026-10-07
- Rugiet Support: treatment response and refundsProvider policy; refund exclusions and 24-hour order-change notice · Checked 2026-10-07
- Rugiet Support: membership options and inclusionsProvider support; plan intervals, shipping, and consultation fees · Checked 2026-10-07
- MedlinePlus: TadalafilDrug information; standard tadalafil products · Checked 2026-10-07
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications · Checked 2026-10-07
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07
- MedlinePlus: SildenafilDrug information; standard sildenafil products · Checked 2026-10-07